Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-α and transforming growth factor-β mRNA production

International Immunology

Volumn 9, Issue 10, 1997, Pages 1405-1413

  Romieu, Raphaëlle ^c   Lacabanne, Valérie ^c   Kayibanda, Michèle ^c   Antoine, Bénédicte ^a   Bennoun, Myriam ^a   Chouaib, Salem ^b   Guillet, Jean Gérard ^c   Viguier, Mireille ^c  

^a INSTITUT COCHIN   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSERM   (France)

Author keywords

Hepatocellular carcinoma; Transforming growth factor ; Tumor growth; Tumor necrosis factor

Indexed keywords

DACTINOMYCIN; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG SENSITIVITY; GENETIC TRANSCRIPTION; GROWTH INHIBITION; GROWTH REGULATION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR GROWTH;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BASE SEQUENCE; CELL DIVISION; CYTOKINES; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOTHERAPY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030874596     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.10.1405     Document Type: Article

References (38)

1. Pardoll, D. M. 1995, Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13:399.
2. Lewis, C. E., Leek, R., Harris, A. and McGee, J. O. 1995. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J. Leuk. Biol. 57:747.
3. Kerbel, R. S. 1992. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Am. J. Pathol. 141:519.
4. Chisari, F. V. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29.
5. Paroli, M., Perrone, A., Bonavita, M. S. and Barnaba, V. 1991. Immunology of hepatocellular carcinoma. Ital. J. Gastroenterol. 1991:494.
6. Kim, J., Modlin, R. L., Moy, R. L., Dubinett, S. M., McHugh, T., Nickoloff, B. J. and Uyemura, K. 1995. IL-10 production in cutaneous basal and squamous cell carcinomas. J. Immunol. 155:2240.
7. Bost, K. L., Bieligk, S. C. and Jaffe, B. M. 1995. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. J. Immunol. 154:718.
8. Lin, W.-C., Yasumura, S., Suminami, Y., Sung, M.-W., Nagashima, S., Stanson, J. and Whiteside, T. L. 1995. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth. J. Immunol. 155:4805.
9. O'Connell, M. A., Cleere, R., Long, A., O'Neill, L. A. and Kelleher, D. 1995. Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT 78. J. Biol. Chem. 270:7399.
10. Aggarwal, B. B. and Natarajan, K. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:93.
11. Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A. and Shepard, H. M. 1985. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943.
12. Leist, M., Gantner, F., Bohlinger, I., Germann, P. G., Tiegs, G. and Wendel, A. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153:1778.
13. Buck, C., Digel, W., Schoniger, W., Stefanic, M., Raghavachar, A., Heimpel, H. and Porzsolt, F. 1990. Tumor necrosis factor-α, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia. Leukemia 4:431.
14. Sporn, M. B., Roberts, A. B., Wakefield, L. M. and Assoian, R. K. 1986. Transforming growth factor-β: biological function and chemical structure. Science 233:532.
15. Reeder, M. K. and Isom, H. C. 1996. Effect of transforming growth factor β on rat hepatocyte cell lines depends upon the state of tumorigenic progression. Cell Growth Different. 7:449.
16. Battegay, E. J. 1995. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Med. 73:333.
17. Ivanovic, V., Melman, A., Davis-Joseph, B., Valcic, M. and Geliebter, J. 1995. Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer. Nat. Med. 1:282.
18. Van Belle, P., Rodeck, U., Nuamah, I., Halpern, A. C. and Elder, D. E. 1996. Melanoma-associated expression of transforming growth factor-β isoforms. Am. J. Pathol. 148:1887.
19. Spriggs, D., Imamura, K., Rodriguez, C., Horiguchi, J. and Kufe, D. W. 1987. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc. Natl Acad. Sci. USA 84:6563.
20. Adams, J. M. and Cory, S. 1991. Transgenic models of tumor development. Science 254:1161.
21. Dubois, N., Bennoun, M., Allemand, I., Molina, T., Grimber, G., Daudet-Monsac, M , Abelanet, R. and Briand, P. 1991. Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. J. Hepatol. 13:227.
22. DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E. and Livingston, D. M. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275.
23. Lane, D. P. and Crawford, L. V. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261.
24. Antoine, B., Levrat, F., Vallet, V., Berbar, T., Cartier, N., Dubois, N., Briand, P. and Kahn, A. 1992. Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice. Exp. Cell Res. 200:175.
25. Levrat, F., Vallet, V., Berbar, T., Miquerol, L., Kahn, A. and Antoine, B. 1993. Influence of the content in transcription factors on the phenotype of mouse hepatocyte-like cell lines (mhAT). Exp. Cell Res. 209:1.
26. Chomczynski, P. and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
27. Shire, D. 1993. An invitation to an open exchange of reagents and information useful for the measurement of cytokine mRNA levels by PCR. Eur. Cytokine Netw. 4:161.
28. Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H. and Fujiwara, H. 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179:1529.
29. Maeda, H. and Shiraishi, A. 1996. TGF-β contributes to the shift toward Th2-type responses throught direct and IL-10-mediated pathways in tumor-bearing-mice. J. Immunol. 156:73.
30. Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H. and Galle, P. R. 1996. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion ? Nat. Med. 2:1361.
31. Ito, N., Kawata, S., Tamura, S., Takaishi, K., Shirai, Y., Kiso, S., Yabuuchi, I., Matsuda, Y., Nishioka, M. and Tarui, S. 1991. Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res. 51:4080.
32. Rodeck, U., Bossier, A., Graeven, U., Fox, F., Nowell, P. and Kari, C. 1994. Transforming growth factor-β production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res. 54:575.
33. Voelkel-Johnson, C., Thorne, T. E. and Laster, S. M. 1996. Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells. J. Immunol. 156:201.
34. Aggarwal, B. B., Eessalu, T. E. and Hass, P. E. 1985. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 318:665.
35. Schwarz, L. C., Gingras, M.-C., Goldberg, G., Greenberg, A. H. and Wright, J. A. 1988. Loss of growth factor dependence and conversion of transforming growth factor-β1 inhibition to stimulation in metastasic H-ras-transformed murine fibroblasts. Cancer Res. 48:6999.
36. Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Münger, K., Howley, P. M. and Moses, H. L. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:775.
37. Ito, N., Kawata, S., Tamura, S., Shirai, Y., Kiso, S., Tsushima, H. and Matsuzawa, Y. 1995. Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma. Cancer Lett. 89:45.
38. Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X.-F., Shizimu, J., Fujiwara, H. and Hamaoka, T. 1991. Transforming growth factor-β-induced inhibition of T cell function. J. Immunol. 146:1077.